The Baylor Difference
The only program of its kind in North Texas, the Skin Malignancy Research and Treatment Center at Baylor Charles A. Sammons Cancer Center, an integral part of Baylor University Medical Center at Dallas, combines the expertise of dermatologists, medical and surgical oncologists to provide a premier destination for the screening, evaluation, research and treatment of malignant skin conditions.
The specialists at the Skin Malignancy Research and Treatment Center use the most advanced techniques to provide expert care for a variety of skin cancers, including:
- Squamous cell carcinoma
- Basal cell carcinoma
Merkel cell carcinoma
- Dermatofibrosarcoma protuberans (DFSP)
- Cutaneous T-cell lymphoma (CTCL)
- Transplant-related skin malignancies
As part of our dedication to multidisciplinary care, the center is closely aligned with the Baylor Annette C. and Harold C. Simmons Transplant Institute. Baylor Simmons Transplant Institute, the third-largest center in the nation, is an internationally renowned destination for transplant care and one of the busiest in the world. Baylor’s Skin Malignancy Research and Treatment Center is one of few national programs participating in a retrospective database for transplant skin malignancies designated by the American Academy of Dermatology.
Our Team Approach
Our team of experts have a steadfast commitment to excellence in the research, prevention, early detection and treatment for patients with skin malignancies. From the moment you choose Baylor for cancer care, you are connected with a patient navigation specialist who will partner with you every step of the way. From diagnosis to survivorship, Baylor is by your side.
Every patient is unique and deserves a personalized plan of care. Our multidisciplinary team of experts participate in monthly cancer conferences where they discuss, evaluate and recommend the best course of treatment for every patient. The care team at the Skin Malignancy Research and Treatment Center includes specialists in the fields of:
Treatment plans for patients for patients with skin malignancies are based on medical history, type and stage of malignant skin condition, and the patient's personal preferences. Treatment options include: